Back to Search
Start Over
ABCL-362: Incidence, Onset, and Management of Myelosuppression in Patients Treated with loncastuximab Tesirine for R/R DLBCL in a Pooled Safety Analysis.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS394-S395, 2p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 21
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 152099215
- Full Text :
- https://doi.org/10.1016/S2152-2650(21)01894-2